Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

18
Number of overlapping holdings
60.0%
% of FBT's 31 holdings also in BMED
17.1%
% of BMED's 115 holdings also in FBT
Overlap by Weight
Sector Drift (FBT minus BMED)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in FBT |
Weight in BMED |
Overlap | |
---|---|---|---|---|
ARGENX SE ADR | 3.4% | 3.3% | 3.3% | |
GILEAD SCIENCES INC | 3.1% | 3.7% | 3.1% | |
REPLIGEN CORP | 3.6% | 2.1% | 2.1% | |
WATERS CORP | 3.3% | 2.0% | 2.0% | |
NEUROCRINE BIOSCIENCES INC | 3.7% | 1.5% | 1.5% |
Position Highlights (Non-Overlapping Exposures)
FBT Overweight Relative to BMED
GENMAB A/S SPONSORED ADR | 3.5% | |
INCYTE CORP | 3.4% | |
REGENERON PHARMACEUTICALS | 3.4% | |
BIOMARIN PHARMACEUTICAL INC | 3.4% | |
ALKERMES PLC | 3.3% | |
CORCEPT THERAPEUTICS INC | 3.3% | |
METTLER-TOLEDO INTERNATIONAL | 3.3% | |
MODERNA, INC. | 3.2% | |
BRUKER CORP | 3.2% | |
ILLUMINA INC | 3.2% |
FBT Underweight Relative to BMED
BOSTON SCIENTIFIC CORP | -4.9% | |
INTUITIVE SURGICAL INC | -4.9% | |
ROCHE HOLDING AG-BR | -3.4% | |
ABBVIE INC | -3.1% | |
LONZA GROUP AG-REG | -2.7% | |
ABBOTT LABORATORIES | -2.7% | |
MEDTRONIC PLC | -2.3% | |
UCB SA | -2.2% | |
BRISTOL-MYERS SQUIBB CO | -2.2% | |
BIO-TECHNE CORPORATION | -1.8% |